MONOCLONETICS INT has a total of 17 patent applications. Its first patent ever was published in 1987. It filed its patents most often in United States, Australia and EPO (European Patent Office). Its main competitors in its focus markets biotechnology, measurement and pharmaceuticals are SARCOTEIN DIAGNOSTICS LLC, NORDIC BIOSCIENCE AS and MATRITECH INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 5 | |
#2 | Australia | 4 | |
#3 | EPO (European Patent Office) | 4 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | Canada | 1 | |
#6 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Pharmaceuticals | |
#4 | Machines |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Analysing materials | |
#3 | Unspecified technologies | |
#4 | Therapeutic chemical compounds | |
#5 | Medical preparations | |
#6 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Merril Carl R | 8 |
#2 | Cameron Bruce M Sr | 7 |
#3 | Vanderputten Dale | 7 |
#4 | Warrington Richard E | 6 |
#5 | Creed Guy Joseph | 4 |
#6 | Khan Abbas A | 3 |
#7 | Creed Guy J | 3 |
#8 | Khan Abas A | 1 |
#9 | De La Parra Jacinto J | 1 |
#10 | De La Parra Jacinto Juarez | 1 |
Publication | Filing date | Title |
---|---|---|
US5844097A | Methods for the diagnosis of peripheral nerve damage | |
WO9210760A1 | Methods for the diagnosis of chronic lower back and cervical pain | |
AU2894889A | Genetic markers for down's syndrome, fetal abnormalities and twins | |
WO9000625A1 | Pre-screening for depletion and enrichment of specific b-cells | |
AU2542488A | Pre-screening for depletion and enrichment of specific b-cells | |
US4782077A | Taliscanin and other aristolactams for treating neurological disorders, Parkinson's disease, Alzheimer disease and impotence | |
US4940659A | Screening extra-cellular body fluids for superoxide dismutase (SOD-1) for determining fetal trisomy 21 down syndrome |